Clinical Trial Update: Short-term Low-dose Low-molecular-weight Heparin to Prevent Postpartum Thrombosis [Phase 3]

View source ↗

Summary

Ongoing Phase 3 clinical trial evaluating short-term low-dose low-molecular-weight heparin to prevent postpartum venous thromboembolism.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Thromboembolism

Drugs mentioned

• Low molecular weight heparin (low molecular weight heparin)

Snippet

Sponsor: Marc Blondon | Conditions: Venous Thromboembolism (VTE), Postpartum | Phase 3 | Status: RECRUITING